uniQure N.V. QURE
$27.17
▲ +2.80% 24H
About
uniQure N.V. is a biopharmaceutical company based in the Netherlands, specializing in the discovery, development, and commercialization of innovative gene therapies for patients with severe genetic and neurological disorders. It leverages a proprietary adeno-associated virus (AAV)-based platform to create one-time admi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryNetherlands
Employees221
TickerQURE
Statistics
Market Cap$1.71B
Revenue (TTM)$16.1M
Net Income-$199.0M
Net Margin-1236.0%
EPS$-3.46
P/E-7.96
P/S96.10
P/B8.64
EV/EBITDA-9.71
ROE-228.2%
Dividend Yield—
Price$27.17
Data: Twelve Data · Revenue = mcap / P/S